Brain Tumours Application

Hanalytics (BioMind)

Assists in the detection, segmentation, differential diagnosis and localization of 22 types of intracranial tumors on MRI scans: chordoma, lymphoma, craniopharyngioma, choroid plexus, papilloma, meningioma, medulloblastoma, epidermoid cyst, pituitary tumor, paraganglioma, germ cell tumor, acoustic neuroma, angioreticuloma, DNET, hemangiopericytoma, pleomorphic yellow, astrocytoma, nodular cell tumor, brain metastases, astrocytoma, oligodendroglioma, glioblastoma, pilocytic astrocytoma, ependymoma, subependymal giant, cell astrocytoma.

Product specifications

Information source: Vendor
Last updated: Dec. 3, 2020

General
Product name	Brain Tumours Application
Company	Hanalytics (BioMind)
Subspeciality	Neuro
Modality	MR
Disease targeted	Brain tumours, brain cancer
Key-features	Brain tumor detection, segmentation and brain region localization, 3D reconstruction, structured report generation
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion After: diagnosis verification
Data characteristics
Population	Patients suspected of brain tumours, not valid for children under 8-year-old
Input	T1, T2, T2 Contrast, Axial
Input format	DICOM
Output	segmentation overlay, brain region overlay, structured report
Output format	DICOM, Nifty
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment	Locally on dedicated hardware, Cloud-based
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	3 - 10 seconds
Certification
CE	Certified, Class IIa , MDD
FDA	No or not yet
Market presence
On market since	12-2017
Distribution channels
Countries present (clinical, non-research use)	27
Paying clinical customers (institutes)	+140
Research/test users (institutes)	15
Pricing
Pricing model	One-off payment
Based on	Number of installations
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers